Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Roivant Sciences founder to step down as CEO

The founder of Roivant Sciences will step down from the role of chief executive officer, the SoftBank-backed biotechnology company said on Monday.

Chief Financial Officer Matt Gline will replace Vivek Ramaswamy, who will step into the role of executive chairman.

The move would "separate my increasing public engagement from Roivant's day-to-day operations", Ramaswamy said in a letter to the company's shareholders.

Japan's Sumitomo Dainippon Pharma Co owns a 10% stake in Roivant.

(Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.